A two-step genome editing strategy has been developed, enabling the creation of full-length humanized mouse models. This approach is reportedly scalable and can be used to generate full-length gene-humanized mice at various genomic locations. The development appears to be related to advances in CRISPR-Cas technology and its applications in precision medicine.